PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 08, 2021 / 01:00PM GMT
Release Date Price: €34.2 (+7.55%)
Operator

Good day, and welcome to PTC Therapeutics 2021 Annual Meeting of Stockholders.

I would like to introduce Chief Executive Officer of PTC Therapeutics, Dr. Stuart Peltz. Dr. Peltz, please commence.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Thank you, and good morning, ladies and gentlemen. Will the meeting please come to order? Thank you.

I'd like to welcome you to the -- to our 2021 Annual Meeting of Stockholders. With us today are members of our Board of Directors and our senior management. Aside from myself, the Board is represented by Michael Schmertzler, Allan Jacobson, Stephanie Okey, Emma Reeve, Glenn Steele, David Southwell, Dawn Svoronos and Jerry Zeldis.

We are also joined by Mary Smith, who has been nominated for election to the Board at this annual meeting. Michael Schmertzler, the Chairperson of the Board of Directors will preside over today's meeting.

The meeting agenda is posted on your screen, and the meeting rules of conduct and procedures are included under the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot